Genomma Lab Columbia

Genomma Lab Columbia is owned by Genomma Lab.

Genomma Lab is a company listed under the stock ticker LABB (MX).

Genomma Lab has a direct presence in 4 countries.

Genomma Lab has 3 subsidiaries including Genomma Lab Argentina, Genomma Lab Columbia and Genomma Lab USA.

They are in:

• Pharmaceuticals75%
• Biotechnology25%

View the org chart displaying its 2 main executives

Most searched biographies at Genomma Lab Columbia

• Grey Brausin, Marketing Director
• Carlos Caro, Global R&D and Regulatory Affairs Director

Create your alert
to follow the executive moves at Genomma Lab Columbia.

Genomma Lab has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Genomma Lab Columbia

Social media about Genomma Lab Columbia

• Genomma Lab Columbia on Wikipedia, Google News & Yahoo Finance
• Genomma Lab Columbia on LinkedIn, Twitter & YouTube

Contact by email its executives including Carlos Caro

Call Genomma Lab Columbia at +57 ...

View the org chart

Register to receive your alert

Report an error